(formerly known as Jia Group Holdings Limited 前稱佳民集團有限公司) Stock code 股份代號 : 8519 於開曼群島註冊成立的有限公司 Incorporated in the Cayman Islands with limited liability 2024 ANNUAL REPORT 年報 ANNUAL REPORT2024 年度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE "STOCK EXCHANGE") GEM has been positioned as a market designed to accommodate small and mid-sized companies to which a higher investment risk may be attached than other companies listed on the Stock Exchange. Prospective investors should be a ...

2024 年度報告 Cancer has no borders. Neither do we. 目錄 | 公司資料 | 2 | | --- | --- | | 前瞻性陳述 | 4 | | 業務 | 8 | | 風險因素 | 43 | | 財務概要 | 129 | | 管理層討論及分析 | 130 | | 董事及高級管理層 | 153 | | 董事會報告 | 162 | | 企業管治報告 | 229 | | 獨立核數師報告 | 259 | | 綜合財務報表 | 264 | | 釋義 | 349 | | 技術詞彙 | 355 | 1 百濟神州有限公司 • 2024 年度報告 公司資料 董事會 執行董事 歐雷強先生 （主席兼首席執行官） 非執行董事 王曉東博士 獨立非執行董事 Olivier Brandicourt博士 （附註1） Margaret Han Dugan博士 Michael Goller先生 Anthony C. Hooper先生 Ranjeev Krishana先生 Alessandro Riva博士 Corazon (Corsee) D. Sanders博士 Shalini Sharp女士 （附註 ...

ANNUAL REPORT 年度報告 2024 目錄 | 公司資料 | 2 | | --- | --- | | 財務概要 | 4 | | 2024榮譽和大事件 | 5 | | 董事長致辭 | 9 | | 管理層討論及分析 | 10 | | 董事、監事及高級管理層履歷 | 28 | | 企業管治報告 | 37 | | 董事會報告 | 54 | | 監事會報告 | 84 | | 獨立核數師報告 | 89 | | 綜合全面收益表 | 96 | | 綜合財務狀況表 | 97 | | 綜合權益變動表 | 99 | | 綜合現金流量表 | 101 | | 綜合財務報表附註 | 103 | | 五年財務概要 | 212 | | 詞彙及釋義 | 214 | 2024 Annual Report 1 公司資料 董事會 執行董事 夏紹飛先生 （董事長） 非執行董事 徐國富先生 吳曉力先生 林可女士 石誠先生 祁詩皓先生 獨立非執行董事 袁林女士 肖慧琳女士 董渙樟先生 監事 余勇先生 駱瑞鋒先生 任文娟女士 聯席公司秘書 徐圓圓女士 劉國賢先生 授權代表 夏紹飛先生 劉國賢先生 審核委員會 董渙樟先生 （主席） 吳曉力先生 袁林 ...

2024 年度報告 ANNUAL REPORT 於中華人民共和國註冊成立之股份有限公司 A joint stock limited liability company established in the People's Republic of China 年度报告 2024 ANNUAL REPORT 創美藥業股份有限公司（股份代號： 2289.HK）主營醫藥分銷業務，主要 向下游分銷商和零售終端分銷西藥、 中成藥、保健品等產品，同時也開展 第三方物流服務，並提供醫藥產品諮 詢服務。本公司創立於 2000 年，經 過 25 年的快速發展，已成長為華南 地區領先的醫藥分銷商之一。本公司 堅持「深耕廣東，輻射周邊」的發展 戰略，立足於汕頭，在廣州、珠海、 惠州、佛山及深圳成立子公司，並擁 有四個現代化醫藥物流中心，專業的 營銷服務團隊以及運輸服務團隊，對 非招標市場實行「半徑 10 公里內一 日三配、50 公里內一日兩配、250 公 里內一日一配」的高效配送機制。本 公司具有現代化信息系統，涵蓋整個 醫藥分銷供應鏈，包括採購、銷售、 倉儲、運輸及交付等。本公司同時運 營自建的 B2B 電子商務平台：「創 美 ...

目 錄 | 企 | 業 | | | | | | | 2 | 訊 | | | | | 資 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 主 | 席 | 致 | | | | | | 4 | 詞 | | | | | | | | | | | | | | 管 | 理 | 層 | | 分 | 析 | | | 6 | 討 | 論 | 及 | | | | | | | | | | | | 董 | 事 | 及 | 管 | 理 | 人 | | | 1 2 | 高 | 級 | | | | | | | | | | 員 | | | 董 | 事 | 會 | | | | | | 1 5 | 報 | 告 | | | | | | | | | | | | | 企 | 業 | 管 | 告 | | | | | 2 6 | 治 | 報 | | | | | | | | | | | | | 環 | 境 ...

Financial Performance - For the first quarter of 2025, the company achieved operating revenue of RMB 5,720,965,040, representing a year-on-year increase of 47.69% compared to RMB 3,873,747,046 in the same period last year[4][9] - The net profit attributable to shareholders of the parent company for the same period was RMB 2,041,982,798, reflecting a significant year-on-year growth of 64.85% from RMB 1,238,666,240[4][9] - The basic earnings per share increased by 71.55% to RMB 0.382, up from RMB 0.223 in the previous year[9][18] - The company reported a net profit excluding non-recurring items of RMB 2,008,455,771, which is a 65.07% increase from RMB 1,216,702,413 in the previous year[9][19] - Net profit for Q1 2025 was RMB 2,044,387,261, representing a 64.9% increase from RMB 1,239,089,337 in Q1 2024[36] - The company reported a net profit of RMB 98,299,737 for Q1 2025, a decrease of 95.1% from RMB 1,986,970,103 in the same quarter last year[43] Cash Flow and Liquidity - The net cash flow from operating activities decreased by 31.38% to RMB 8,793,070,123, down from RMB 12,814,865,518 in the same period last year[9][19] - Operating cash flow decreased by 31.38% to ¥8,793,070,123, primarily due to reduced cash inflows from financial instruments held for trading[22] - The net cash flow from operating activities for Q1 2025 was RMB 4,914,979,976, down 43.5% from RMB 8,628,609,356 in Q1 2024[44] - Cash flow from investment activities showed a net outflow of RMB 1,046,406,291, contrasting with a net inflow of RMB 4,289,700,093 in the previous year[45] - Net cash flow from investing activities was negative at ¥-1,392,132,913, reflecting increased cash payments for investments[22] - Net cash flow from financing activities was negative at ¥-10,478,440,949, due to decreased cash inflows from issuing debt instruments[22] Assets and Liabilities - Total assets at the end of the reporting period were RMB 673,200,948,427, a slight decrease of 0.22% from RMB 674,715,821,446 at the end of the previous year[10] - Total liabilities decreased to RMB 555,724,781,523 from RMB 559,094,150,638, indicating a reduction of approximately 0.7%[33] - The total assets as of March 31, 2025, were RMB 327,602,300,109, down from RMB 336,796,609,098 at the end of 2024[40] - The total liabilities decreased to RMB 240,240,709,816 as of March 31, 2025, compared to RMB 249,315,377,539 at the end of 2024[41] Equity and Investments - The total equity attributable to shareholders of the parent company increased by 1.57% to RMB 117,152,834,492 from RMB 115,347,607,754[10] - The company’s total equity as of March 31, 2025, was RMB 87,361,590,293, a slight decrease from RMB 87,481,231,559 at the end of 2024[41] - The company reported investment income of RMB 4,244,768,778 for Q1 2025, up from RMB 3,435,648,963 in Q1 2024[35] - Investment income for Q1 2025 was RMB 1,214,999,018, a significant recovery from a loss of RMB 485,982,202 in Q1 2024[42] Expenses and Tax - Tax expenses increased by 94.16% to ¥370,748,737, driven by an increase in total profit[21] - Business and management expenses rose by 37.00% to ¥3,280,813,570, reflecting higher employee costs due to improved operational performance[21] - Total operating expenses surged to RMB 1,626,416,201, compared to RMB 601,917,027 in Q1 2024, reflecting a year-over-year increase of 169.5%[42] Other Financial Metrics - The risk coverage ratio improved to 219.10% from 188.54% in the previous year, indicating enhanced risk management[13] - The liquidity coverage ratio significantly increased to 371.61% from 224.00% year-on-year, reflecting better liquidity management[13] - The company’s cash and cash equivalents rose to RMB 131,172,724,121 from RMB 128,501,125,589[32] - The ending cash and cash equivalents balance as of March 31, 2025, was RMB 45,401,859,910, down from RMB 52,052,365,913 at the end of Q1 2024[46]

Plus Group Holdings Inc. 普樂師集團控股有限公司 (A company incorporated in the Cayman Islands with limited liability) Stock code 股份代號 : 2486 （於開曼群島註冊成立的有限公司） ANNUAL REPORT 2024年 報 Plus Group Holdings Inc. 普樂師集團控股有限公司 Plus Group Holdings Inc. 普樂師集團控股有限公司 ANNUAL REPORT 2024 CONTENTS 目錄 | Definitions | 2 | | --- | --- | | 釋義 | | | Corporate Information | 6 | | 公司資料 | | | Financial and Operational Highlights | 9 | | 財務及營運概要 | | | Chairman's Statement | 12 | | 主席報告書 | | | Management Discussion and Analysis | 16 | | 管理層討論與分 ...

Financial Performance - Revenue for the year reached RMB 27,328 million, representing a year-on-year increase of 33.8%[21] - EBITDA was RMB 5,553 million, reflecting a year-on-year growth of 32.8%[21] - Earnings per share increased by 142.9% to RMB 1.53[21] - Free cash flow decreased by 22.4% to RMB 2,954 million, with capital expenditure accounting for 42.0% of EBITDA[21] - Net assets grew by 3.3% to RMB 23,117 million, while the net asset liability ratio was 3.8%[21] - Revenue for 2023 was RMB 20,419,072 thousand, with a projected increase to RMB 27,328,304 thousand in 2024, representing a growth of 33.8%[22] - Net profit attributable to shareholders increased significantly from RMB 740,370 thousand in 2023 to RMB 1,797,230 thousand in 2024, marking a 142.7% increase[22] - Operating cash flow reached RMB 5.2 billion, indicating a strong financial foundation[39] - The gross profit margin improved to 22.1% in 2024, up by 5.2 percentage points from 16.9% in 2023[22] - The overall revenue for 2024 increased by 33.8% to RMB 27.33 billion, driven by a rise in PSS-related business revenue by RMB 3,494.6 million[54] Research and Development - The company invested 7.4% of its revenue in R&D for 2024, maintaining a strong focus on technological innovation[17] - The company holds a total of 5,112 patents, with an additional 2,752 patents pending[17] - Research and development expenses accounted for 7.4% of revenue in 2024, slightly down from 7.7% in 2023[22] - Research and development expenses increased by 28.5% to RMB 2.02 billion in 2024, reflecting additional investments in new projects[59] - The company is focusing on high-performance products in the sensor and semiconductor segment, with a leading market share in high signal-to-noise ratio microphones[52] Strategic Focus and Market Expansion - Strategic focus includes expanding into smartphone, smart automotive, VR/AR, and smart home sectors[10] - The company aims to enhance production efficiency through the development of automated equipment and flexible production lines[20] - The company aims to enhance its core business through innovations in acoustics, optics, and electromagnetic transmission, targeting growth in consumer electronics and automotive sectors[39] - Future growth opportunities are anticipated in the consumer electronics sector, driven by edge AI deployment and the expansion of markets such as electric vehicles and AR/VR[53] Acquisitions and Investments - The company completed the first phase acquisition of Premium Sound Solutions (PSS) in February 2024, positively impacting profits and providing new momentum in the automotive market[39] - AAC Technologies (Belgium) BV agreed to purchase 100% of Acoustics Solutions International B.V. in two batches, with the first batch representing 80% of the issued shares[135] - The acquisition aims to diversify the company's automotive business and enhance its audio solution offerings, creating synergies with existing strengths[138] Corporate Governance - The company has established an Enterprise Risk Management (ERM) framework to effectively identify, assess, mitigate, and monitor sustainability risks[77] - The company emphasizes sustainability in its governance structure, with a dedicated Sustainability Committee[107] - The board includes members with significant international experience, which may aid in market expansion strategies[95][99][103] - The independent directors have no relationships with other board members or major shareholders, ensuring unbiased governance[97][101][104] - The company has committed to high standards of corporate governance, ensuring compliance with all relevant codes throughout the fiscal year[183] Sustainability and Social Responsibility - The company has implemented a comprehensive climate change policy to drive sustainability efforts, incorporating ISO environmental and energy management standards[85] - The company made donations amounting to approximately RMB 1,050,000 for community medical welfare, poverty alleviation, and educational support[171] - The sustainable development committee was established in May 2024 to enhance governance in sustainability[189] Financial Policies and Risk Management - The company will maintain a prudent financial policy and strong cash flow to support business development and create long-term value for shareholders[119] - The company has established a robust financial risk management policy, detailed in its annual report[118] - The company focuses on reducing liquidity and interest rate risks by maintaining an appropriate RMB/USD borrowing mix[86] Employee and Shareholder Information - The company employed 37,273 full-time employees, a 25% increase from 29,922 employees on December 31, 2023, with 11% of the increase attributed to the acquisition of PSS[177] - The board proposed a final dividend of HKD 0.24 per share for the fiscal year 2024, up from HKD 0.10 per share in fiscal year 2023, maintaining a 15% payout ratio[119] - The company has established a compensation policy for senior management and directors, which is reviewed by the compensation committee[155] Supply Chain and Procurement - The group entered into procurement agreements with suppliers, with a maximum annual limit of RMB 140,000 thousand for materials and products[144] - The company has a total of 3,344 square meters of warehouse space leased in Vietnam, with an expected annual rent of USD 160,600[143] - The company’s largest supplier accounted for approximately 8.0% of total procurement, with the top five suppliers making up 22.9% of total procurement[178]

年報目錄 關於我們 P2 公司簡介 P4 五年數據摘要 管理層討論與分析 公司管治 | P39 | 公司治理報告 | P68 | 董事會報告 | | --- | --- | --- | --- | | P103 | 獨立非執行董事履職報告 | P114 | 監事會報告 | 財務報表 P118 獨立核數師報告 P123 綜合損益及其他全面收益表 P125 綜合財務狀況表 P128 綜合權益變動表 P130 綜合現金流量表 P132 綜合財務表附註 其他信息 中遠海運能源運輸股份有限公司 2024 年度報告 1 P5 公司所從事的主要業務、經營模式及行業情況說明 P9 國際國內能源運輸市場分析 P13 經營業績回顧 P20 成本及費用分析 P21 合營公司及聯營公司經營情況 P22 財務狀況分析 P30 船隊發展 P31 二零二五年前景展望 P250 公司資料 P252 董事、監事及高級管理人員簡歷 公司簡介 中遠海運能源運輸股份有限公司（簡稱「中遠海運能源」或「本公司」，連同其附屬公司，統稱「本集團」）是中國遠 洋海運集團有限公司（「中遠海運」，連同其附屬公司，統稱「中遠海運集團」）旗下從事油品及液化天然氣等能 ...

目錄 公司資料 2 董事長報告 4 財務概要 10 管理層討論及分析 12 董事、監事及高級管理層 19 企業管治報告 28 董事會報告 49 監事會報告 63 環境、社會及管治報告 66 獨立核數師報告 107 合併綜合虧損表 113 合併資產負債表 114 合併權益變動表 116 合併現金流量表 117 合併財務報表附註 118 釋義及技術詞彙表 207 2 2024年年度報告 公司資料 項陽博士 譚開國先生 （主席） 譚明奎博士 薪酬委員會 項陽博士 譚開國先生 譚明奎博士 （主席） 董事會 執行董事 劉國清博士 （董事長兼總經理） 楊廣先生 周翔先生 王啟程先生 非執行董事 畢壘先生 劉怡然女士 獨立非執行董事 項陽博士 譚開國先生 譚明奎博士 監事 廖迪廣先生 （監事會主席） 敖爭光先生 宛浩先生 審計委員會 提名委員會 劉國清博士 項陽博士 （主席） 譚明奎博士 戰略委員會 劉國清博士 （主席） 楊廣先生 譚明奎博士 聯席公司秘書(1) 羅希文女士 林穎芝女士(ACG, HKACG) 授權代表 劉國清博士 林穎芝女士 核數師 羅兵咸永道會計師事務所 執業會計師 註冊公眾利益實體核數師 香港 中環 ...